1. Foghorn hits NASDAQ in $120M debut as biotech IPO keeps rolling — Bayer drug shown to slow diabetic kidney disease — Another opioid exec heads to prison — See more on our front page news Stay updated with the latest pharma-related coronavirus news on our new page
    Dismiss Notice
  2. Please take our quick survey on how COVID-19 is impacting your job It will only take a minute or two to respond. The survey is confidential, and does not require registration. Thank you in advance for your participation. We will provide regular updates on results as responses accumulate.
    Dismiss Notice

Citizens Rx

Anonymous board for Citizens Rx


Sort By:
Title
Replies Views ↓
Last Message
  1. There are no threads to display.

Thread Display Options

Loading...